{
"id":"mk19_bb_on_s2",
"subspecialtyId":"on",
"title":"Lung Cancer",
"jsonContent":{
"type":"section",
"id":"mk19_bb_on_s2",
"title":{
"__html":"Lung Cancer"
},
"titleNode":{
"type":"section-title",
"hlId":"487c76",
"children":[
"Lung Cancer"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_on_s2_1",
"title":{
"__html":"Screening and Prevention"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6ef8",
"children":[
"Screening and Prevention"
]
},
"children":[
{
"type":"p",
"hlId":"cc5108",
"children":[
"Smoking cessation is the most effective preventive measure for lung cancer."
]
},
{
"type":"p",
"hlId":"fcdea0",
"children":[
"Annual screening with low-dose CT in patients aged 55 to 74-80 years (guidelines vary) with a 30-pack-year history of smoking, including those who quit smoking in the preceding 15 years, is associated with a decrease in lung cancer and all-cause mortality."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"cff3b0",
"children":[
"Do not prescribe vitamin A derivatives (β-carotene and retinol) or vitamin E (α-tocopherol) to prevent lung cancer."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s2_2",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"84cce9",
"children":[
"The most characteristic finding is a mass lesion on chest x-ray. Radiographic abnormalities should first be compared with previous chest imaging studies. A solid lung nodule that has been stable for 2 years or longer is highly unlikely to be cancer. Histologic confirmation is necessary for diagnosis."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s2_3",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"8d7f40",
"children":[
"Biopsy can distinguish tumors as either ",
{
"type":"abbreviation",
"title":"non–small cell lung cancer",
"children":[
"NSCLC"
]
},
" or ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"small cell lung cancer",
"children":[
"SCLC"
]
},
"."
]
},
" ",
{
"type":"alert",
"children":[
"Select the biopsy site that will simultaneously diagnose and stage the disease (peripheral lymph node, mediastinal node)"
]
},
"."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s2_4",
"title":{
"__html":"Small Cell Lung Cancer"
},
"titleNode":{
"type":"section-title",
"hlId":"fdfe2c",
"children":[
"Small Cell Lung Cancer"
]
},
"children":[
{
"type":"p",
"hlId":"1c247d",
"children":[
"SCLC is generally viewed as a systemic (metastatic) disease at the time of diagnosis. Limited-stage disease is confined to one hemithorax, with hilar and mediastinal lymphadenopathy that can be encompassed within one tolerable radiotherapy portal. Extensive-stage disease consists of any disease that exceeds those boundaries, including malignant pleural effusion. Typical staging studies include CT of the chest, abdomen, and pelvis. Whole-body CT/",
{
"type":"abbreviation",
"title":"positron emission tomography",
"children":[
"PET"
]
},
" scan and MRI of the brain should be done even in the absence of bone or ",
{
"type":"abbreviation",
"title":"central nervous system",
"children":[
"CNS"
]
},
" symptoms."
]
},
{
"type":"p",
"hlId":"eec697",
"children":[
"SCLC is associated with paraneoplastic syndromes such as hyponatremia from the ",
{
"type":"abbreviation",
"title":"syndrome of inappropriate antidiuretic hormone secretion",
"children":[
"SIADH"
]
},
" and hypercortisolism through secretion of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"adrenocorticotropic hormone",
"children":[
"ACTH"
]
},
"."
]
},
" Neurologic symptoms, such as the Lambert-Eaton syndrome, cortical cerebellar degeneration, limbic encephalitis, and peripheral neuropathy, may rarely occur."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s2_5",
"title":{
"__html":"Non–Small Cell Lung Cancer"
},
"titleNode":{
"type":"section-title",
"hlId":"c5cc28",
"children":[
"Non–Small Cell Lung Cancer"
]
},
"children":[
{
"type":"p",
"hlId":"c6b891",
"children":[
"NSCLC is categorized as early stage, locally advanced, or metastatic. Early-stage disease is resectable. Locally advanced disease is defined by clinically detectable mediastinal lymphadenopathy or invasion into local structures. Metastatic disease is defined as spread of the tumor to distant sites."
]
},
{
"type":"p",
"hlId":"28d2fb",
"children":[
"PET scan/CT and whole-body PET scan are used for staging. Brain MRI is indicated in the presence of neurologic signs or symptoms or in patients being considered for surgery or combined modality (chemoradiation) therapy for early-stage lung cancer."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s2_6",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_on_s2_inline_t1",
"mk19_bb_on_s2_inline_t2"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"265a17",
"children":[
"For patients with ",
{
"type":"abbreviation",
"title":"epidermal growth factor receptor",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"EGFR"
]
}
]
},
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"/ALK/ROS1"
]
},
" mutations, use targeted therapy with a tyrosine kinase inhibitor."
]
},
{
"type":"p",
"hlId":"d02e69",
"children":[
"Use glucocorticoids and radiation therapy for patients with multiple brain metastases. Select thoracic irradiation for pulmonary airway obstruction, ",
{
"type":"abbreviation",
"title":"superior vena cava",
"children":[
"SVC"
]
},
" syndrome, and spinal cord metastases (following surgical decompression). Radiation therapy relieves pain from metastatic disease. Treat symptomatic pleural effusions with thoracentesis and indwelling pleural catheter or pleurodesis if necessary."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"19466e",
"children":[
"Avoid chemotherapy in patients with NSCLC with poor performance status (extreme fatigue or weakness, weight loss >10%, severe symptoms)."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_on_s2_7",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"ae6805",
"class":"test",
"children":[
"A 59-year-old woman has a right lower lobe mass, bulky mediastinal lymph nodes, and hilar lymphadenopathy. Biopsy confirms non–small cell lung cancer. No evidence of metastatic disease is seen."
]
},
{
"type":"p",
"hlId":"e8517f",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For treatment, select combined chemotherapy and radiation."
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_on_s2_inline_t1":{
"id":"mk19_bb_on_s2_inline_t1",
"number":1,
"bookId":"on",
"title":{
"__html":"Study Table: Treatment of SCLC"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"121584",
"children":[
"Study Table: Treatment of SCLC"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd4b4a",
"class":"col hd l",
"children":[
"If you see this…"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"36f00f",
"class":"col hd l",
"children":[
"Select this…"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1afa6c",
"class":"cell txt l",
"children":[
"Limited-stage disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ff0e1",
"class":"cell txt l",
"children":[
"Concurrent, platinum-based combined chemotherapy and radiation therapy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"74bed4",
"class":"cell txt l",
"children":[
"Extensive-stage disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2dc96e",
"class":"cell txt l",
"children":[
"Platinum-based combined chemotherapy and immunotherapy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2fc6e",
"class":"cell txt l",
"children":[
"Complete or partial response to therapy (limited-stage disease and possibly extensive-stage disease with good performance status)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f7820d",
"class":"cell txt l",
"children":[
"Add prophylactic cranial irradiation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b7bb0b",
"class":"cell txt l",
"children":[
"Symptomatic brain metastases"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"941e41",
"class":"cell txt l",
"children":[
"Radiation therapy"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_on_s2_inline_t2":{
"id":"mk19_bb_on_s2_inline_t2",
"number":2,
"bookId":"on",
"title":{
"__html":"Study Table: Treatment of NSCLC"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"bd9d68",
"children":[
"Study Table: Treatment of NSCLC"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd4b4a",
"class":"col hd l",
"children":[
"If you see this…"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"36f00f",
"class":"col hd l",
"children":[
"Select this…"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"561e30",
"class":"cell txt l",
"children":[
"Early-stage disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7481cc",
"class":"cell txt l",
"children":[
"Surgical resection for cure"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8fd1c3",
"class":"cell txt l",
"children":[
"Locally advanced disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ee6f7b",
"class":"cell txt l",
"children":[
"Platinum-based chemotherapy and radiation therapy; immunotherapy added for responders."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac8a13",
"class":"cell txt l",
"children":[
"Metastatic disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1d24dd",
"class":"cell txt l",
"children":[
"Tyrosine kinase inhibitor–specific therapy for tumors with driver mutations (see following); immunotherapy, platinum-based chemotherapy, or both for tumors without a driver mutation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0c7948",
"class":"cell txt l",
"children":[
"Solitary brain metastasis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c3a3ee",
"class":"cell txt l",
"children":[
"Surgical excision and postoperative brain radiation"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}